Dev Group Retreat 2025: Translating #ProstateCancer science into clinical impact - from early detection to novel biomarkers. New results & opportunities coming soon - watch this space! Supported by: @PCR_News@PCFnews John Black Foundation @ProstateUK@AstraZeneca@CRUKCamCentre
We’re hiring a Computational Postdoctoral Researcher (Bioinformatics) to join the Dev Group @EarlyCancerCam. Early lethal prostate cancer, epigenetics + liquid biopsies, building on upcoming work and featured in @Telegraph this month.
https://t.co/LWCBEf6gQz
A clinical trial led by members of our @CRUKCamUrol
has revealed how a short course of targeted therapy prior to surgery can influence the biology of prostate cancer – even in men who do not carry known DNA repair gene mutations.
Find out more ➡️https://t.co/lMUeXQrPrN
A major moment for prostate cancer screening at PMQs today. @RishiSunak highlighted the urgent need for action and referenced the vital work of Prostate Cancer Research. We're delighted @Keir_Starmer was so supportive!
Join us and let's make this a reality: https://t.co/5ZzAkVyCFJ
Following the sad news about Sir Chris Hoy you might have questions about prostate cancer.
Click below to find out more about prostate cancer, how it's diagnosed and treated 👇
"I hope my sons never get cancer, but I wanted to support the research that might help them if they ever did.”
Andrew Pickering has been taking part in a trial @CUH_NHS of new & repurposed drugs for #ProstateCancer
See how he's #ChangingTheStoryOfCancer with @CRUKCamCentre 👇
https://t.co/q69E3Rw1t3{SOCIAL_NETWORK}
Imagine a future where no one dies from #cancer.
With @CUH_NHS we’re building @CambCancer, a new hospital where scientists and doctors will work alongside patients to transform how we diagnose and treat cancer.
Cambridge is #ChangingTheStoryOfCancer 👉 https://t.co/Q4ex7IUU9l
Well done to our 'Early Cancer Detectives' team who took part in the Cambridge @raceforlife on Sunday. It was a great event to be a part of, raising funds for groundbreaking research.
There's still time to donate at: https://t.co/pbk5Ota1QO
Cutting Edge Letters: Ultrasensitive Detection of Circulating Tumour DNA enriches for Patients with a Greater Risk of Recurrence of Clinically Localised Prostate Cancer
Read it here:
https://t.co/uNgNjBSZlM
@loki_phd@danbrewer @davidcwedge @harveerdev#Medtwitter#UroSoMe